Esanik Therapeutics, Inc.

CIK 2044524 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Esanik Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Apr 30, 2026D0002044524-26-000003
Nov 14, 2024D0002044524-24-000001